Dr. Chaitanya Borde

Consultant - Nuclear Medicine

Home / Our Doctors / Dr. Chaitanya Borde

Consultant - Nuclear Medicine

Book Appointment

Consultant - Nuclear Medicine

Qualification

MBBS, DNB, DRM

Experience

12 Years

Specialities

Email

with Dr. Chaitanya Borde

Dr. Borde has 12 years of experience in the field of nuclear medicine and has gained proficient skills and knowledge in those segments.
He is well-versed in all types of nuclear scans , PET-CT scans , nuclear cardiology services with experience & skills acquired from RMC , TMH , Mumbai.
He has proficiency in radioiodine & Lu-177 RN therapies.
He has handled more than 30,000 PET scans and 1000 thyroid cancer patients.

Malignant epidermoid arising from the third ventricle: A case report. World J Radiol. 2019 May 28;11(5):74-80.
18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today? Nucl Med Commun. 2018 Jul;39(7):583-592.
Increasing cardiac 18F- fluorodeoxyglucose (FDG) uptake on PET-CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: a myth or a reality? Radiother Oncol. 2014 Sep;112(3):451-2.
Papillary carcinoma thyroid with uveal metastases. Clin Nucl Med. 2013 Feb;38(2):131-4.
Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? World J Radiol. 2012 May 28;4(5):220-3.
Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-
flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation. Hell J Nucl Med. 2011 Jan-Apr;14(1):72-3.
FDG PET/CT in evaluation of Cancer Cervix: Defined role & exploring opportunities. Indian J Cancer (provisionally accepted).